KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Operating Expenses (2016 - 2026)

Zimmer Biomet Holdings has reported Operating Expenses over the past 18 years, most recently at $1.7 billion for Q1 2026.

  • For Q1 2026, Operating Expenses rose 5.98% year-over-year to $1.7 billion; the TTM value through Mar 2026 reached $7.2 billion, up 13.21%, while the annual FY2025 figure was $7.1 billion, 11.58% up from the prior year.
  • Operating Expenses for Q1 2026 was $1.7 billion at Zimmer Biomet Holdings, down from $2.1 billion in the prior quarter.
  • Over five years, Operating Expenses peaked at $2.1 billion in Q4 2025 and troughed at $1.4 billion in Q3 2022.
  • A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: dropped 14.43% in 2023 and later rose 27.84% in 2025.
  • Year by year, Operating Expenses stood at $1.9 billion in 2022, then dropped by 14.43% to $1.6 billion in 2023, then rose by 3.05% to $1.6 billion in 2024, then grew by 27.84% to $2.1 billion in 2025, then dropped by 17.99% to $1.7 billion in 2026.
  • Business Quant data shows Operating Expenses for ZBH at $1.7 billion in Q1 2026, $2.1 billion in Q4 2025, and $1.7 billion in Q3 2025.